NCT07043829

Brief Summary

This non-randomized acute clinical trial evaluates the effect of consuming a water-based solution of Cimarrón bean extrudate on platelet function and postprandial glycemia in adults. Participants will consume a single 10-gram dose of Cimarrón bean extrudate dissolved in water. Blood samples will be collected before and after the intervention to assess platelet reactivity using flow cytometry and to measure glucose levels through colorimetric spectrophotometry. The total intervention period will last approximately 8 hours. This study aims to explore whether the acute consumption of this legume-based functional product can influence hemostatic and glycemic responses in the postprandial state.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Mar 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 13, 2025

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 19, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 19, 2025

Completed
1 day until next milestone

First Submitted

Initial submission to the registry

June 20, 2025

Completed
9 days until next milestone

First Posted

Study publicly available on registry

June 29, 2025

Completed
9 months until next milestone

Results Posted

Study results publicly available

April 9, 2026

Completed
Last Updated

April 9, 2026

Status Verified

December 1, 2025

Enrollment Period

3 months

First QC Date

June 20, 2025

Results QC Date

December 28, 2025

Last Update Submit

March 23, 2026

Conditions

Keywords

Phaseolus vulgarisPlatelet reactivityFuntional foodLegume-base foodPlatelet activation

Outcome Measures

Primary Outcomes (1)

  • Change in Platelet Reactivity After Acute Consumption of SPVCE

    The platelet reactivity was assessed in response to three agonists: ADP, CRP, and TRAP-6. The expression changes of P-selectin and the binding of Fibrinogen to the platelet were measured at baseline (0 hours) and 6 hours. The data were analyzed using dose-response curves and derived metrics of these curves, including basal activity (minimum), maximal response (maximum), EC50, and Capacity of response as the difference between the maximal response and the basal state.

    Baseline (0 hours) and 6 hours post-intervention

Secondary Outcomes (3)

  • Change in Postprandial Blood Glucose Levels After Consumption of SPVCE

    Baseline and up to 2 hours post-intervention

  • Change in Postprandial Plasma Concentration of Total Polyphenols After Consumption of SPVCE

    0 minutes (baseline) 2 hour and 6 hours postprandial.

  • Change in Postprandial Platelet Function (Closure Time) After Consumption of SPVCE

    Baseline (0 hours) and 6 hour post-intervention.

Study Arms (1)

SPVCE Intervention

EXPERIMENTAL

Participants will receive a single oral dose of 10 grams of SPVCE. Platelet function (Reactivity and blood risk), postprandial glycemia and Polyphenol concentration will be measured before and after the intervention.

Dietary Supplement: SPVCE (Solution Phaseolus vulgaris L. var. Cimarrón Extrudate in Water)

Interventions

A single oral dose of 10 grams of Cimarrón bean (Phaseolus vulgaris L., variety Cimarrón) extrudate dissolved in 500 mL of water, consumed once under fasting conditions, to evaluate acute effects on platelet function (reactivity and blood risk), postprandial glycemia, and total polyphenol concentration at baseline (0 hours), 2 hours, and 6 hours after SPVCE consumption.

Also known as: SAEP (Solution of Cimarrón Bean Extrudate in Water)
SPVCE Intervention

Eligibility Criteria

Age20 Years - 59 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Voluntary participant
  • Men and women aged 20-59 years
  • Willingness to participate and provide written informend consent

You may not qualify if:

  • Documented food allergies, especially ti legumes or beans
  • Diagnosed liver, kidney, , autoinmune diseases or severe illnesses such as cancer.
  • Diagnosed gastrointestinal diseases including inflammatory bowel disease (e.g., Crohn's disease, ulcerative colitis), celiac disease, or any condition causing chronic gastrointestinal symptoms such as malabsorption, persistent diarrhea, or gastrointestinal bleeding
  • Use medication known to alter platelet funtion like, antiplatelet agents (aspirin, clopidogrel); Non-steroidal anti-inflamatory drugs (NSAID-Ibuprofen, naproxen); Anticoagulants (Warfarin, heparin, direct oral anticoagulant like rivaroxaban or apixaban); Selective serotonin reuptake inhibitors (SSRIs) and other drugs known to impact platelet aggregation or hemostasis.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Universidad de Talca

Talca, Maule Region, 3460057, Chile

Location

MeSH Terms

Interventions

Water

Intervention Hierarchy (Ancestors)

HydroxidesAlkaliesInorganic ChemicalsAnionsIonsElectrolytesOxidesOxygen Compounds

Results Point of Contact

Title
Iván Francisco Palomo González
Organization
University of Talca

Study Officials

  • Ivan F Palomo Gonzalez, PhD. Biomedical Science

    University of Talca

    PRINCIPAL INVESTIGATOR
  • Eduardo J Fuentes Quinteros, PhD. Science research

    University of Talca

    STUDY CHAIR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
SINGLE GROUP
Model Details: A single-group, open-label clinical trial in which all participants receive a single dose of a functional beverage containing 10 grams of Cimarrón bean extrudate dissolved in water. No placebo or comparator group is included. Outcomes are measured before and after the intervention within the same participants to assess acute changes in platelet function and postprandial glycemia.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

June 20, 2025

First Posted

June 29, 2025

Study Start

March 13, 2025

Primary Completion

June 19, 2025

Study Completion

June 19, 2025

Last Updated

April 9, 2026

Results First Posted

April 9, 2026

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will not share

Individual participant data (IPD) will not be shared. As stated in the informed consent, participation is strictly confidential; participant names and identifiers are not used. Blood samples are coded and not linked to personal data. Identity and health information will not be disclosed or shared outside the study team.

Locations